C4 Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
C4 Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • C4 Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $296K, a 35.4% decline year-over-year.
  • C4 Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.32M, a 32% decline year-over-year.
  • C4 Therapeutics, Inc. annual Depreciation for 2023 was $1.58M, a 5.85% decline from 2022.
  • C4 Therapeutics, Inc. annual Depreciation for 2022 was $1.68M, a 12.3% increase from 2021.
  • C4 Therapeutics, Inc. annual Depreciation for 2021 was $1.49M, a 7.73% decline from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.58M -$98K -5.85% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $1.68M +$184K +12.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $1.49M -$125K -7.73% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 $1.62M +$22K +1.38% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $1.6M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.